Fundraising FoxBay City Capital — 2017 Investments
4 investments dated 2017 · listed companies and verified rows first · show all
HealthtechSt Paul, US
Dan W Gladney(Executive Officer, Director)Scott P Youngstrom(Executive Officer)Rajesh Nihalani(Executive Officer)Peter M DeLange(Executive Officer)inPaul F Hickey(Executive Officer)inNaqeeb A Ansari(Executive Officer)
Board seatCarl Goldfischer· per SEC Form D
Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.
BiotechSouth San Francisco, US
John F. Fowler(Executive Officer, Director)inChristopher J. Kirk(Executive Officer, Director)
BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)
Co-investorsChiesi VenturesPappas CapitalQiming Venture Partners USASolasta VenturesCowen Healthcare InvestmentsEcoR1 Capital+1 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.